Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Financials
OTC Markets’ second-quarter figures showed lower pre-tax profit year-on-year, but this should be seen in the context of the company’s successful long-term development of its cost-effective, transparent markets, OTCQX and OTCQB. This is a year in which it is investing in technology, acquisitions and staff, as well as moving into new headquarters. While we have trimmed our estimates, we look for a return to profit growth in FY20 and for long-term cash flows to benefit from the investments being made.
Written by
OTC Markets Group |
A year of investment for the future |
Q219 results |
Financial services |
14 August 2019 |
Share price performance
Business description
Next events
Analysts
OTC Markets Group is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||
OTC Markets’ second-quarter figures showed lower pre-tax profit year-on-year, but this should be seen in the context of the company’s successful long-term development of its cost-effective, transparent markets, OTCQX and OTCQB. This is a year in which it is investing in technology, acquisitions and staff, as well as moving into new headquarters. While we have trimmed our estimates, we look for a return to profit growth in FY20 and for long-term cash flows to benefit from the investments being made.
Year end |
Revenue ($m) |
PBT |
EPS* |
DPS** |
P/E |
Yield |
12/17 |
54.7 |
18.4 |
1.06 |
1.16 |
32.1 |
3.4 |
12/18 |
59.3 |
19.8 |
1.36 |
1.23 |
24.9 |
3.6 |
12/19e |
62.8 |
18.2 |
1.25 |
1.27 |
27.2 |
3.7 |
12/20e |
66.6 |
21.0 |
1.43 |
1.33 |
23.8 |
3.9 |
Note: *Fully diluted and calculated after restricted stock award allocation. **Including special dividends declared and estimated of 60c, 65c, 67c and 73c for FY17–20e, respectively.
Q219 results
Revenues increased 6% y-o-y with the most rapid growth in Corporate Services, where a combination of healthy net client gains for OTCQX and implementation of a price increase for OTCQB last year delivered a 9% advance. Operating expenses (+15%) outpaced this growth with staff costs accounting for most of the change followed by IT, infrastructure and information services. Acquisitions contributed to both, while recruitment and investment in IT to sustain development of the business also played a part. Pre-tax profits and diluted EPS fell by 11%. Other operational highlights included further growth in the number of OTC Link ECN subscribers and, within Market Data Licensing, in the number of compliance file professional market data users. Two further states have granted OTCM’s premium markets Blue Sky recognition, taking the total to 36 for OTCQX,covering 55% of the US population.
Market background and outlook
While the main North American equity markets have made progress in the year to date, venture markets have been relatively weak and, with geopolitical uncertainty a feature globally, the near-term outlook for business confidence is unclear. Nevertheless, OTCM remains consistent in its commitment to developing its markets and enhancing its offering to corporate clients and market users through new products, technology investments and acquisitions. The long-term outlook for its cost-effective secondary markets still appears promising, particularly as online capital raising gains momentum.
Valuation: Estimates trimmed, valuation held
We have reduced our EPS estimates for this year and next by 6% and 3% respectively, reflecting a higher run rate of costs than we previously allowed. However, longer-term cash flows are likely to benefit from new products and services and the net impact on cash flow estimates is modest. On balance, our fair value is unchanged at $37.00 per share (see page 6).
Q219 results analysis
Exhibit 1 provides a comparison of OTCM’s Q219 profit and loss result with prior quarters and we pick out key points below. Percentage changes cited are from Q218 unless stated.
■
Gross revenue was 6% ahead with Corporate Services showing the strongest growth at 9%, reflecting the benefit of an increased number of corporate clients at OTCQX and the benefit of price increases for OTCQB introduced in 2018.
■
Within OTC Link revenues, OTC Link ECN, which provides alternative functionality to traders, contributed $0.33m, up from $0.23m reflecting its increasing traction with 47 subscribers in Q219 versus 35.
■
The Virtual Investor Conferences (acquired in Q119) contributed $0.1m of revenue in the quarter, hosting seven conferences with 79 companies and reaching over 6,000 investors.
■
Operating expenses increased 15% with the main drivers being compensation and IT and information service costs, in part arising from the acquisitions of Qaravan and Virtual Investor Conferences in the prior quarter (see further analysis of expenses in Exhibit 2).
■
As a result, pre-tax profits were down 11% but increased (by nearly 10%) sequentially as Q119 bore $0.467m of one-off costs relating to the company’s move to its new headquarters at 300 Vesey Street. Excluding this, profits would have been down less than 2% q-o-q.
■
OTCM declared a maintained quarterly dividend of $0.15.
Exhibit 1: Q219 P&L results summary
$000s (except where stated) |
Q218 |
Q418 |
Q119 |
Q219 |
y-o-y % |
q-o-q % |
OTC Link |
2,799 |
2,918 |
2,843 |
2,898 |
3.5 |
1.9 |
Market Data Licensing |
5,830 |
5,949 |
6,071 |
6,077 |
4.2 |
0.1 |
Corporate Services |
6,137 |
6,538 |
6,442 |
6,695 |
9.1 |
3.9 |
Gross revenues |
14,766 |
15,405 |
15,356 |
15,670 |
6.1 |
2.0 |
Re-distribution fees and rebates |
(632) |
(609) |
(626) |
(637) |
0.8 |
1.8 |
Net revenue |
14,134 |
14,796 |
14,730 |
15,033 |
6.4 |
2.1 |
Transaction-based expenses |
(78) |
(147) |
(140) |
(172) |
120.5 |
22.9 |
Revenues less transaction-based expenses |
14,056 |
14,649 |
14,590 |
14,861 |
5.7 |
1.9 |
Operating expenses |
(9,060) |
(9,842) |
(10,568) |
(10,434) |
15.2 |
(1.3) |
Income from operations |
4,996 |
4,807 |
4,022 |
4,427 |
(11.4) |
10.1 |
Other income / net interest |
11 |
37 |
37 |
23 |
109.1 |
(37.8) |
Income before provision for income taxes |
5,007 |
4,844 |
4,059 |
4,450 |
(11.1) |
9.6 |
Taxes |
(1,020) |
(726) |
(512) |
(883) |
(13.4) |
72.5 |
Net income |
3,987 |
4,118 |
3,547 |
3,567 |
(10.5) |
0.6 |
Diluted EPS $ |
0.34 |
0.34 |
0.30 |
0.30 |
(11.0) |
1.0 |
Operating margin |
35% |
32% |
27% |
29% |
||
Tax rate |
20% |
15% |
13% |
20% |
Source: OTCM, Edison Investment Research
Exhibit 2 gives a more detailed analysis of costs and, as mentioned, this underlines the significant increase in compensation and IT-related costs. The increase in staff costs partly reflects a rise in staff numbers from 91 at end June last year to 99 this year. This arises from the acquisitions and additions to support development of the business. OTCM reports that the employment market remains competitive, particularly in IT, and the annual increase in base salaries was approximately 6% to aid retention of skilled staff. The sharp, 19%, increase in IT costs was a result of acquisitions and the need to ensure the security and reliability of systems, not least because of obligations under regulation Systems Compliance and Integrity (SCI). Otherwise, occupancy costs were up by a third year-on-year but down by nearly 30% sequentially, reflecting the increased costs related to the new headquarters year-on-year and, quarteronquarter, the one-off move costs incurred in Q119. As shown on the bottom row of the table, excluding those one-off costs, total costs were only modestly ahead sequentially.
Exhibit 2: Analysis of operating expenses
$000s unless stated |
Q218 |
Q418 |
Q119 |
Q219 |
y-o-y % |
q-o-q % |
|
Compensation and benefits |
5,879 |
6,075 |
6,996 |
6,754 |
14.9 |
(3.5) |
|
IT Infrastructure and information services |
1,353 |
1,477 |
1,527 |
1,614 |
19.3 |
5.7 |
|
Professional and consulting fees |
595 |
519 |
400 |
546 |
(8.2) |
36.5 |
|
Marketing and advertising |
269 |
402 |
251 |
242 |
(10.0) |
(3.6) |
|
Occupancy costs |
452 |
750 |
846 |
605 |
33.8 |
(28.5) |
|
Excluding $0.26m overlapping rent cost |
586 |
||||||
Depreciation and amortization |
271 |
260 |
279 |
380 |
40.2 |
36.2 |
|
General, administration and other |
241 |
359 |
269 |
293 |
21.6 |
8.9 |
|
Total |
9,060 |
9,842 |
10,568 |
10,434 |
15.2 |
7.4 |
|
Excluding $0.467m one-off HQ move costs |
10,101 |
10,434 |
3.3 |
||||
Source: OTCM, Edison Investment Research
We show selected quarterly operating metrics in Exhibit 3.
Within OTC Link the two features to note are the progressive addition of new subscribers to OTC Link ECN and a resumption of the erosion in the number of active Link ATS participants as the longer-term trend towards consolidation continues in response to margin and other pressures.
The Corporate Services figures show an increase in the number of OTCQX companies with stronger sales in FY18 and H119, fewer downgrades and a higher retention rate for FY19 (94%) all contributing to the 15% y-o-y increase. International companies (primarily Canadian and including companies in the cannabis-related sector) are noted as a growth driver with 19 joining in the period. OTCQB saw a modest reduction in its corporate client count compared with the prior-year period, with a lower number of new joiners in the quarter and a similar level of cancellations.
Within Market Data Licensing there was a near 4% increase in professional users year-on-year while the relatively volatile (and lower revenue) non-professional users declined by 9%. Not shown in the table but compliance file users (a growth area for OTCM) increased from 22 to 31 y-o-y and at 1 August had grown to 33 custodians, banks and broker dealers.
Exhibit 3: Operating and related revenue data
Q218 |
Q318 |
Q418 |
Q119 |
Q219 |
% change y-o-y |
% change q-o-q |
|
OTC Link |
|||||||
Number of securities quoted |
10,476 |
10,121 |
10,042 |
10,091 |
10,645 |
1.6 |
5.5 |
Number of active ATS participants |
95 |
97 |
91 |
97 |
90 |
(5.3) |
(7.2) |
Number of ECN subscribers |
35 |
36 |
41 |
42 |
45 |
28.6 |
7.1 |
Revenue per security quoted ($) |
267 |
277 |
291 |
282 |
272 |
1.9 |
(3.4) |
Revenue per average active participant ($) |
29,619 |
29,240 |
31,043 |
30,245 |
30,995 |
4.6 |
2.5 |
Corporate Services |
|||||||
Number of corporate clients |
|||||||
OTCQX |
365 |
395 |
409 |
414 |
421 |
15.3 |
1.7 |
OTCQB |
922 |
953 |
934 |
941 |
916 |
(0.7) |
(2.7) |
Pink |
761 |
736 |
741 |
740 |
747 |
(1.8) |
0.9 |
Total |
2,048 |
2,084 |
2,084 |
2,095 |
2,084 |
1.8 |
(0.5) |
Revenue per client ($) |
2,997 |
2,973 |
3,137 |
3,075 |
3,213 |
7.2 |
4.5 |
Graduates to a national securities exchange |
20 |
16 |
13 |
12 |
13 |
(35.0) |
8.3 |
Market Data Licensing |
|||||||
Market data professional users |
20,951 |
20,991 |
21,487 |
21,776 |
21,766 |
3.9 |
(0.0) |
Market data non-professional users |
15,389 |
14,661 |
14,763 |
14,976 |
13,991 |
(9.1) |
(6.6) |
Revenue per terminal (total - $) |
160 |
162 |
164 |
165 |
170 |
5.9 |
2.9 |
Source: OTCM, Edison Investment Research
Two further states, Kentucky and North Dakota, have been added to the list of those that grant Blue Sky recognition to the OTCQX and OTCQB markets. This takes the totals to 36 states for OTCQX and 33 for OTCQB (see Exhibit 4). As a result, population coverage now stands at 55% and over 53%, respectively. OTCM continues to work towards further regulatory recognition and it is hoped that adoption of a model rule by the North American Securities Administrators Association will facilitate further states granting recognition. Blue Sky recognition is not directly linked to revenue generation but progress towards 100% coverage should be increasingly positive reputationally, helping to attract a broader range of corporate clients to OTCM’s premium markets.
Exhibit 4: States that have granted Blue Sky recognition for OTCQX and OTCQB
Alaska |
Louisiana |
Oregon |
Arkansas |
Maine |
Pennsylvania |
Colorado |
Michigan |
Rhode Island |
Connecticut |
Minnesota |
South Dakota |
Delaware |
Mississippi |
Tennessee |
Georgia |
Missouri |
Texas |
Hawaii |
Nebraska |
Utah |
Idaho (OTCQX only) |
New Jersey |
Vermont (OTCQX only) |
Indiana |
New Mexico |
Washington |
Iowa |
North Dakota |
West Virginia |
Kansas (OTCQX only) |
Ohio |
Wisconsin |
Kentucky |
Oklahoma |
Wyoming |
Source: OTCM
OTCM highlighted three new product developments launched in the second quarter, examples of the company’s initiatives to broaden its offering and enhance its services to its corporate customers and market users.
1.
An OTCQX Cannabis Index has been launched including 30 of the c 63 companies in this sector on OTCQX, effectively highlighting companies with the requisite disclosure and liquidity levels for inclusion.
2.
Qaravan (provider of bank risk and performance analytics and related software) launched a CECL solution to address the new expected credit loss accounting standard. The accounting standard is due to come into play for larger companies with accounting periods beginning on or after 15 December this year although FASB has voted to postpone implementation for smaller companies (to January 2023).
3.
A web-based tool, Canari, gives subscribers a comprehensive view of quantitative compliance data available for companies on the two premium OTCM markets and the Pink and Grey segments. The hope is that this tool will help further the growth in the user base for OTCM compliance data noted above.
Background and outlook
To set the scene we include our normal table showing the recent performance of selected equity market indices (Exhibit 5). This shows positive performance for all but OTCQB year to date. The markets with more of a venture profile, OTCQB, TSX Venture and AIM, have all been weaker than the remaining markets, reflecting a cyclical period of outperformance for larger companies.
Exhibit 5: Recent market index performance (total return %)
Period |
S&P 500 |
Nasdaq Composite |
OTCQX Composite |
OTCQB |
S&P TSX Venture |
AIM All-Share |
US$ |
US$ |
US$ |
US$ |
C$ |
£ |
|
3 months |
2.2 |
0.9 |
8.1 |
-13.3 |
0.2 |
-6.8 |
6 months |
8.9 |
9.7 |
19.5 |
-15.6 |
-3.0 |
-1.3 |
1 year |
4.4 |
2.0 |
4.2 |
-15.9 |
-15.0 |
-17.5 |
Year to date |
17.8 |
20.7 |
25.7 |
-6.0 |
6.6 |
4.1 |
Source: Bloomberg. Note: Priced on 12 August 2019.
Exhibit 6 and 7 show IPO numbers for Nasdaq, and the Canadian TSX and TSX Venture exchanges as indicators of corporate and market confidence and activity. This broadly shows a similar pattern to the equity index performance outlined above. The number of IPOs on Nasdaq in the second quarter was 7% above the prior-year period at 60, while the first half count was 4% higher at 97. On the Canadian exchanges, TSX IPOs in the first four months of the year were down 3%, whereas TSX Venture was 19% below the prior-year period. Not shown here, but the number of new admissions to AIM in the first seven months of 2019 were down 62% with the marked weakness likely to reflect continuing political uncertainties in the UK.
|
Exhibit 6: Nasdaq – number of IPOs |
Exhibit 7: TSX and TSX Venture – number of IPOs |
|
|
|
Source: Nasdaq |
Source: TMX |
|
Exhibit 6: Nasdaq – number of IPOs |
|
|
Source: Nasdaq |
|
Exhibit 7: TSX and TSX Venture – number of IPOs |
|
|
Source: TMX |
Near-term market dynamics such as those highlighted above may affect activity levels for OTCM including trading activity for OTC Link and the appetite of corporates to sign up to its services, but on a longer view development of online/crowdfunding capital raising could create a larger population of potential clients with an appetite to use OTCM’s cost effective secondary markets. On this front the extension of Regulation A+ to SEC reporting issuers in January was seen as a positive development while OTCM also welcomes the publication of the SEC’s Harmonisation of Securities Offering Exemptions concept release that seeks feedback on ways to simplify and improve the framework of offering exemptions to ease capital raising while still protecting investors.
OTCM’s own focus and strategy is unchanged, aiming to create better informed and more efficient financial markets through sharing information on open networks, connecting broker-dealers to create organised markets and providing reliable, cost-effective, subscription-based technology solutions.
Financials
The changes in key numbers within our estimates are summarised in Exhibit 8, with further detail included in the financial summary in Exhibit 11. Our revenue assumptions are marginally higher with small increases for OTC Link and Corporate Services and reductions for Corporate Services. We had already increased our operating expense assumption after the Q1 results and now make a further 3% increase to allow for the investment the company has made in staff and IT costs. The resulting EPS estimate reductions are 6% and 3% for this year and next.
Exhibit 8: Estimate revisions
|
Gross revenue ($m) |
PBT ($m) |
Fully diluted EPS ($) |
Dividend ($) |
||||||||
|
Old |
New |
Change (%) |
Old |
New |
Change (%) |
Old |
New |
Change (%) |
Old |
New |
Change (%) |
2019e |
62.5 |
62.8 |
0.5 |
19.3 |
18.2 |
-5.5 |
1.34 |
1.25 |
-6.4 |
1.27 |
1.27 |
0.0 |
2020e |
65.8 |
66.6 |
1.2 |
21.8 |
21.0 |
-3.5 |
1.47 |
1.43 |
-3.3 |
1.33 |
1.33 |
0.0 |
Source: Edison Investment Research. Note: Dividends include estimated special dividends of 67c and 73c for FY19 and FY20, respectively.
The balance sheet remains strong with net cash of $24.1m at the end of the quarter ($22.4m end Q119) or $25.7m including restricted cash. First-quarter cash flow showed a spike in spending within investing activities, reflecting the cash element of the Qaravan acquisition, spending associated with the headquarters move and data-centre upgrades. The headquarters and acquisition spending dropped out in the second quarter, but data centre investment has continued and is expected to be completed by the end of 2019. Absent further acquisition opportunities, we expect investment spending to revert to a lower level, with a figure of $1.3m assumed in our estimate for FY20, for example.
Valuation
OTCM shares are up 24% year to date compared with 48% for the information providers and 29% for global exchanges on average. This, combined with earnings estimate changes (consensus for global exchanges and information providers), has left OTCM on prospective PERs below those for information providers and similar to the average for global exchanges (see Exhibit 9 below).
Exhibit 9: OTCM comparative multiples
P/E ratios (x) |
||
2019e |
2020e |
|
MSCI |
35.0 |
30.7 |
Markit |
24.5 |
21.7 |
Average information providers |
29.8 |
26.2 |
Average global exchanges |
27.0 |
23.5 |
OTCM |
27.2 |
23.8 |
Source: Refinitiv, Edison Investment Research. Note: Prices as at 12 August 2019.
The sensitivity of our discounted cash flow valuation to different discount rate and long-term growth assumptions is illustrated in the next table. The model factors in our explicit forecasts for FY19/20 together with an assumption of FY21–22 cash flow growth of 5%, long-term growth of 4% and a terminal cash flow multiple of c 22x, compared with the current year value of 27x.
Exhibit 10: Discounted cash flow valuation sensitivity ($ per share)
Discount rate (right) |
8% |
9% |
10% |
11% |
12% |
3% |
40.8 |
37.9 |
35.3 |
33.0 |
30.8 |
4% |
42.8 |
39.7 |
37.0 |
34.5 |
32.2 |
5% |
44.9 |
41.7 |
38.8 |
36.1 |
33.7 |
6% |
47.1 |
43.7 |
40.6 |
37.8 |
35.2 |
Source: Edison Investment Research
While our FY19 and FY20 estimates have been reduced, it reflects the effect of investment in new products, acquisitions and staff that should generate increased revenue growth and hence improved cash flows. Our longer-term cash flow assumptions are little changed and, taking this and the comparator valuations into account, we keep our fair value unchanged at $37.00 per share.
Exhibit 11: Financial summary
$000s |
2015 |
2016 |
2017 |
2018 |
2019e |
2020e |
Year end 31 December |
||||||
PROFIT & LOSS |
||||||
OTC Link |
11,796 |
10,573 |
10,074 |
11,175 |
11,558 |
12,078 |
Market Data Licensing |
20,610 |
21,054 |
21,922 |
23,384 |
24,561 |
26,035 |
Corporate Services |
17,503 |
19,254 |
22,660 |
24,719 |
26,637 |
28,502 |
Revenue |
49,909 |
50,881 |
54,656 |
59,278 |
62,756 |
66,615 |
Re-distribution fees and rebates |
(2,379) |
(2,317) |
(2,480) |
(2,448) |
(2,485) |
(2,536) |
Net revenue |
47,530 |
48,564 |
52,176 |
56,830 |
60,272 |
64,078 |
Transaction-based expenses |
0 |
0 |
0 |
(375) |
(656) |
(686) |
Revenues less transaction-based expenses |
47,530 |
48,564 |
52,176 |
56,455 |
59,616 |
63,393 |
Operating expenses |
(28,972) |
(30,032) |
(32,511) |
(35,768) |
(40,083) |
(41,036) |
EBITDA |
18,558 |
18,532 |
19,665 |
20,687 |
19,533 |
22,356 |
Depreciation |
(1,692) |
(1,606) |
(1,361) |
(1,042) |
(1,419) |
(1,462) |
Operating profit |
16,866 |
16,926 |
18,304 |
19,645 |
18,114 |
20,895 |
Net interest |
27 |
9 |
47 |
116 |
106 |
110 |
Profit Before Tax |
16,893 |
16,935 |
18,351 |
19,761 |
18,220 |
21,005 |
Tax |
(6,635) |
(6,407) |
(5,792) |
(3,524) |
(3,240) |
(3,991) |
Profit after tax |
10,258 |
10,528 |
12,559 |
16,237 |
14,980 |
17,014 |
Profit after tax and allocation to RSAs |
9,971 |
10,252 |
12,241 |
15,840 |
14,635 |
16,669 |
Average Number of Shares Outstanding (m) |
11.3 |
11.3 |
11.6 |
11.6 |
11.7 |
11.7 |
EPS - basic (c) |
90.6 |
92.4 |
109.9 |
140.8 |
128.9 |
146.8 |
Fully diluted EPS (c) |
88.3 |
90.4 |
105.8 |
136.3 |
125.2 |
142.6 |
Dividend per share (c) |
108.0 |
116.0 |
116.0 |
123.0 |
127.0 |
133.4 |
EBITDA Margin (%) |
39 |
38 |
38 |
36 |
32 |
35 |
Operating profit margin (%) |
35 |
35 |
35 |
35 |
30 |
33 |
BALANCE SHEET |
||||||
Non-current assets |
|
|
|
|
|
|
Intangible assets |
291 |
291 |
362 |
312 |
265 |
319 |
Property and other |
4,187 |
3,267 |
3,506 |
4,584 |
25,259 |
25,044 |
Current assets |
|
|
|
|
|
|
Debtors |
6,082 |
6,262 |
6,450 |
4,942 |
5,111 |
5,111 |
Cash & cash investments |
23,925 |
25,034 |
23,683 |
28,813 |
26,773 |
32,109 |
Other current assets |
1,729 |
1,789 |
2,316 |
2,998 |
2,466 |
2,466 |
Current liabilities |
|
|
|
|
|
|
Deferred revenues |
(12,737) |
(14,664) |
(15,531) |
(16,070) |
(17,517) |
(18,743) |
Other current liabilities |
(5,063) |
(5,372) |
(5,644) |
(6,711) |
(6,808) |
(6,808) |
Long-term liabilities |
|
|
|
|
|
|
Tax, rent and other |
(867) |
(1,101) |
(1,351) |
(2,459) |
(17,738) |
(17,738) |
Net assets |
17,547 |
15,506 |
13,791 |
16,409 |
17,811 |
21,759 |
NAV per share ($) |
1.55 |
1.36 |
1.21 |
1.42 |
1.53 |
1.87 |
CASH FLOW |
||||||
Operating cash flow |
22,400 |
21,752 |
21,629 |
24,442 |
22,691 |
26,033 |
Net Interest |
27 |
9 |
47 |
116 |
106 |
110 |
Tax |
(5,320) |
(6,021) |
(5,193) |
(1,968) |
(2,985) |
(3,991) |
Capex / intangible investment |
(940) |
(415) |
(1,165) |
(549) |
(5,397) |
(1,300) |
Financing / investments |
(420) |
(1,157) |
(3,407) |
(2,716) |
(1,679) |
0 |
Dividends |
(12,094) |
(13,059) |
(13,262) |
(14,195) |
(14,775) |
(15,516) |
Net cash flow |
3,653 |
1,109 |
(1,351) |
5,130 |
(2,040) |
5,336 |
Opening net (debt)/cash |
20,272 |
23,925 |
25,034 |
23,683 |
28,813 |
26,773 |
Closing net (debt)/cash |
23,925 |
25,034 |
23,683 |
28,813 |
26,773 |
32,109 |
Cash and restricted cash |
24,135 |
25,244 |
24,375 |
30,534 |
28,333 |
33,669 |
Source: OTC Markets Group accounts, Edison Investment Research
|
|
ADL Bionatur Solutions (ADL-BS) announced on 12 August 2019 that it has agreed to obtain €25m in debt financing with Kartesia, a private lender, at a rate of Euriobor plus 5% per year with a one-time 7% fee on repayment. Gross proceeds will be used to fully fund the company’s existing capex plans to modernise ADL-BS’s contract manufacturing (CMO) facilities (totalling 2,400m3 in fermentation capacity), to provide the working capital needed to respond to its CMO client demands, and to refinance €5.7m of existing debt. Altogether, ADL-BS expects this debt financing to fully fund the company’s business plan for the next four years, mitigating financing uncertainties and allowing the company to focus on executing its business plan.